Endocrine disorders and metabolic diseases are often quite complex and typically involve the regulation of various body functions. Charles River’s expertise in this therapeutic area includes the progression and analysis of compounds and agents targeting a wide range of conditions, including diabetes, obesity, bone disease, thyroid disease, metabolic disorders, cholesterol and lipid disorders, among several others.